Zeneyedpour, L.; Stingl, C.; Kros, J.M.; Sillevis Smitt, P.A.E.; Luider, T.M.
Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma. Int. J. Mol. Sci. 2022, 23, 5061.
https://doi.org/10.3390/ijms23095061
AMA Style
Zeneyedpour L, Stingl C, Kros JM, Sillevis Smitt PAE, Luider TM.
Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma. International Journal of Molecular Sciences. 2022; 23(9):5061.
https://doi.org/10.3390/ijms23095061
Chicago/Turabian Style
Zeneyedpour, Lona, Christoph Stingl, Johan M. Kros, Peter A. E. Sillevis Smitt, and Theo M. Luider.
2022. "Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma" International Journal of Molecular Sciences 23, no. 9: 5061.
https://doi.org/10.3390/ijms23095061
APA Style
Zeneyedpour, L., Stingl, C., Kros, J. M., Sillevis Smitt, P. A. E., & Luider, T. M.
(2022). Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma. International Journal of Molecular Sciences, 23(9), 5061.
https://doi.org/10.3390/ijms23095061